110 related articles for article (PubMed ID: 31391385)
1. Transporter-Targeted Bile Acid-Camptothecin Conjugate for Improved Oral Absorption.
Xiao L; Zhou Y; Zhang X; Ding Y; Li Q
Chem Pharm Bull (Tokyo); 2019 Oct; 67(10):1082-1087. PubMed ID: 31391385
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Liver Targeting of Camptothecin via Conjugation with Deoxycholic Acid.
Xiao L; Yu E; Yue H; Li Q
Molecules; 2019 Mar; 24(6):. PubMed ID: 30917485
[TBL] [Abstract][Full Text] [Related]
3. Redox sensitive lipid-camptothecin conjugate encapsulated solid lipid nanoparticles for oral delivery.
Du Y; Ling L; Ismail M; He W; Xia Q; Zhou W; Yao C; Li X
Int J Pharm; 2018 Oct; 549(1-2):352-362. PubMed ID: 30099214
[TBL] [Abstract][Full Text] [Related]
4. Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM-camptothecin conjugate.
Ma P; Sun Y; Chen J; Li H; Zhu H; Gao X; Bi X; Zhang Y
Drug Deliv; 2018 Nov; 25(1):153-165. PubMed ID: 29282992
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of some bile acid-based camptothecin analogues.
Li X; Zhao T; Cheng D; Chu C; Tong S; Yan J; Li QY
Molecules; 2014 Mar; 19(3):3761-76. PubMed ID: 24662087
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
7. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.
He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L
Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Metabolism of E2, G2: Novel Bile Acid-Coupling Camptothecin Analogues, in Rat Liver Microsomes.
Zhang X; Shen Q; Wang Y; Zhou L; Weng Q; Li Q
Recent Pat Anticancer Drug Discov; 2021; 16(2):258-272. PubMed ID: 33563179
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
[TBL] [Abstract][Full Text] [Related]
10. Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22.
Yang A; Liu Z; Yan B; Zhou M; Xiong X
Drug Deliv; 2016 Jun; 23(5):1699-706. PubMed ID: 25148540
[TBL] [Abstract][Full Text] [Related]
11. Amphiphilic star PEG-Camptothecin conjugates for intracellular targeting.
Omar R; Bardoogo YL; Corem-Salkmon E; Mizrahi B
J Control Release; 2017 Jul; 257():76-83. PubMed ID: 27677603
[TBL] [Abstract][Full Text] [Related]
12. Self-aggregates of 3,6-O,O'-dimyristoylchitosan derivative are effective in enhancing the solubility and intestinal permeability of camptothecin.
Silva DS; Almeida A; Prezotti FG; Facchinatto WM; Colnago LA; Campana-Filho SP; Sarmento B
Carbohydr Polym; 2017 Dec; 177():178-186. PubMed ID: 28962756
[TBL] [Abstract][Full Text] [Related]
13. Nanocarrier improves the bioavailability, stability and antitumor activity of camptothecin.
Tang XJ; Han M; Yang B; Shen YQ; He ZG; Xu DH; Gao JQ
Int J Pharm; 2014 Dec; 477(1-2):536-45. PubMed ID: 25445532
[TBL] [Abstract][Full Text] [Related]
14. Transporter-targeted cholic acid-cytarabine conjugates for improved oral absorption.
Zhang D; Li D; Shang L; He Z; Sun J
Int J Pharm; 2016 Sep; 511(1):161-169. PubMed ID: 27377011
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and optimization of a bifunctional hyaluronan-based camptothecin prodrug.
Xu Z; Zheng W; Yin Z
Arch Pharm (Weinheim); 2014 Apr; 347(4):240-6. PubMed ID: 24402828
[TBL] [Abstract][Full Text] [Related]
16. Tumor-targeted and activated bioconjugates for improved camptothecin delivery.
Paranjpe PV; Stein S; Sinko PJ
Anticancer Drugs; 2005 Aug; 16(7):763-75. PubMed ID: 16027527
[TBL] [Abstract][Full Text] [Related]
17. Antitumor potential of a novel camptothecin derivative, ZBH-ZM-06.
Wu D; Zhao DW; Li YQ; Shi WG; Yin QL; Tu ZK; Yu YY; Zhong BH; Yu H; Bao WG
Oncol Rep; 2018 Feb; 39(2):871-879. PubMed ID: 29251321
[TBL] [Abstract][Full Text] [Related]
18. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.
Fan W; Xia D; Zhu Q; Li X; He S; Zhu C; Guo S; Hovgaard L; Yang M; Gan Y
Biomaterials; 2018 Jan; 151():13-23. PubMed ID: 29055774
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice.
Schluep T; Cheng J; Khin KT; Davis ME
Cancer Chemother Pharmacol; 2006 May; 57(5):654-62. PubMed ID: 16133526
[TBL] [Abstract][Full Text] [Related]
20. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
Koo OM; Rubinstein I; Onyuksel H
Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
